Biotech

All Articles

James Wilson leaving behind Penn to launch 2 new biotechs

.After more than 30 years, genetics treatment innovator James Wilson M.D., Ph.D., is leaving behind ...

3 biotechs attempt to defeat the summer season heat by dropping workers

.As biotechs attempt to turn a new web page in August, a minimum of 3 providers have dropped staff i...

venBio raises $528M for fifth life scientific researches VC fund

.Veteran venture capital company venBio has raised another half a billion bucks to buy biotechs deal...

Otsuka pays $800M for Jnana as well as its clinical-stage PKU medicine

.Otsuka Drug has picked up Boston-based Jnana Rehabs for $800 thousand so the Oriental biotech can a...

FibroGen gives up 75% of US personnel as property flunks 2 additional tests

.FibroGen is radically restructuring its company, laying off 75% of its USA personnel as well as qui...

Tracon wane full weeks after injectable PD-L1 prevention neglect

.Tracon Pharmaceuticals has decided to relax functions full weeks after an injectable invulnerable g...

Ideaya bags option on Biocytogen bispecific ADC in $400M bargain

.Ideaya Biosciences is actually betting $400 thousand in biobucks that a bispecific antibody-drug co...

Takeda takes $140M loss on neglected epilepsy medicine, proclaims FDA operate

.Our experts already recognize that Takeda is actually hoping to find a road to the FDA for epilepsy...

VBI Injections files for bankruptcy, seeks resource sale

.Immunology biotech VBI Injections is drifting alarmingly near to the climax, with strategies to app...

Celldex anti-cKIT antibody minimize colonies in yet another period 2 research study

.It is actually challenging to muscle in on a room as competitive as immunology, yet Celldex Therape...